Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health,

where we bring evidence, experience, and perspective to make sense of today's leading health challenges.

If you have questions or ideas for us, please send an email to public health question at jhhhu.edu.

That's public health question at jhhu.edu for future podcast episodes.

Hey listeners, it's Lindsay Smith-Rogers. Today, the federal court case on vaccine policy.

I speak with Sarah Daypre, an expert in immunization

policy about the details of the case and its immediate impacts on vaccine policy, innovation,

and public opinion. We also talk about the potentially larger meaning of the decision on HHS Secretary

Robert F. Kennedy Jr.'s approach to vaccine policy. Let's listen.

Sarah DePray, thank you so much for joining us again on public health on call. How are you?

Good, thanks. How are you? I'm great. Today we're going to talk to you about the federal court case

involving vaccine policy. But before we get to that, would you just give us a brief intro of you and your work?

Yeah, sure, happy to. I'm a lawyer by training. I spent about 13 years on Capitol Hill

working on the Senate side and mostly on the House side on the Energy and Commerce Committee

and the House Oversight Committee focused primarily on public health, including vaccine policy.

I then went to the Pew Charitable Trust, where I ran the Government Relations Division for their

public health portfolio and then joined the Biden administration on day two or day three of the

administration and was there serving as a counselor to Secretary Bacera on public health for four

years. And I'm currently a consultant working for several nonprofits, focused primarily on immunization

issues. So describe this court case to us. What happened here? What was the decision?

Yeah. So the American Academy of Pediatrics and a number of other public health

and professionals groups and professional societies sued HHS regarding the decisions that

...